Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy
Abstract Background Duchenne muscular dystrophy (DMD) is caused by loss of dystrophin expression and leads to severe ambulatory and cardiac function decline. However, the dystrophin-deficient mdx murine model of DMD only develops a very mild form of the disease. Our group and others have shown vascu...
Main Authors: | Nadia Milad, Zoe White, Arash Y. Tehrani, Stephanie Sellers, Fabio M.V. Rossi, Pascal Bernatchez |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-09-01
|
Series: | Skeletal Muscle |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13395-017-0135-9 |
Similar Items
-
Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy
by: Azeez Aranmolate, et al.
Published: (2017-08-01) -
Natural history of Duchenne muscular dystrophy
by: Qing KE, et al.
Published: (2015-05-01) -
Altered visual processing in the mdx52 mouse model of Duchenne muscular dystrophy
by: Mirella Telles Salgueiro Barboni, et al.
Published: (2021-05-01) -
Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies
by: Elisabeth Le Rumeur
Published: (2015-07-01) -
Progress study of the cardiac damage in Duchenne muscular dystrophy
by: Yao ZHANG, et al.
Published: (2013-05-01)